Comtripsy Tablets: Uses, Strengths, Benefits, Side Effects & FAQs

Comtripsy Tablets are prescription anticancer medicines containing trifluridine and tipiracil. Marketed by Intas Pharmaceuticals Ltd., Comtripsy is used under specialist supervision for certain advanced cancers, particularly colorectal cancer that has spread to other parts of the body. Treatment suitability depends on the patient's diagnosis, previous therapies, and the prescribing oncologist's assessment.

Comtripsy Tablet Composition and Available Strengths

Comtripsy combines two active ingredients that work together to help control cancer cell growth. The available strengths include:

Comtripsy 15 mg/6.14 mg Tablet: Trifluridine 15 mg + Tipiracil 6.14 mg.

Comtripsy 20 mg/8.19 mg Tablet: Trifluridine 20 mg + Tipiracil 8.19 mg.

Other strength combinations may also be listed by pharmacies. Confirm the exact composition, packaging, and availability with the supplier before ordering.

Uses of Comtripsy Tablets

Comtripsy is prescribed for eligible patients with advanced or metastatic colorectal cancer, particularly when previous cancer treatments have not provided sufficient benefit or are no longer suitable. Depending on the applicable product approval and clinical circumstances, trifluridine and tipiracil combinations may also be used for certain advanced gastric or gastro-oesophageal junction cancers.

This medicine must be prescribed and monitored by an oncologist. It is not intended for self-medication or for treating cancer without a confirmed diagnosis.

Benefits of Comtripsy Tablets

Comtripsy offers the following potential clinical benefits when prescribed appropriately:

Helps control cancer growth: Trifluridine interferes with DNA synthesis in cancer cells.

Supports anticancer activity: Tipiracil slows the breakdown of trifluridine, helping maintain its activity in the body.

Provides an oral treatment option: Tablets can be taken at home according to the oncologist's treatment schedule.

May help manage advanced disease: In eligible patients, treatment may help delay disease progression.

Individual outcomes vary, and the medicine does not guarantee a cure.

Comtripsy Tablet Side Effects

Common side effects may include nausea, vomiting, diarrhoea, abdominal pain, fatigue, reduced appetite, anaemia, low white blood cell counts, low platelet counts, and fever.

Important safety information: Comtripsy can cause serious reductions in blood cell counts, increasing the risk of infection, bleeding, and other complications. Seek prompt medical attention for fever, unusual bleeding, severe weakness, or persistent diarrhoea. Regular blood tests are essential during treatment.

Tell your oncologist about all medicines you take, existing medical conditions, and any pregnancy or breastfeeding considerations. Effective contraception may be necessary during treatment and for the recommended period afterward.

Frequently Asked Questions About Comtripsy Tablets

1. What is Comtripsy Tablet used for?

It is used to treat certain advanced cancers, especially metastatic colorectal cancer, when prescribed by an oncologist.

2. What are the ingredients in Comtripsy?

It contains trifluridine and tipiracil in a fixed-dose combination.

3. How should Comtripsy Tablets be taken?

Follow your oncologist's exact dosage and treatment schedule. Swallow tablets whole as directed and do not change or stop treatment without medical advice.

4. What are the common side effects?

Nausea, diarrhoea, fatigue, vomiting, appetite loss, anaemia, and reduced blood cell counts are possible.

5. Is Comtripsy available without a prescription?

No. It is a specialist prescription medicine that requires medical supervision and regular monitoring.

6. Where can I check Comtripsy availability?

Contact a licensed pharmacy or authorised pharmaceutical supplier to confirm the required strength, current availability, batch details, and applicable prescription requirements.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice. Always consult a qualified oncologist before starting or changing cancer treatment.